AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bellevue Healthcare Trust PLC

Share Issue/Capital Change Nov 3, 2023

4961_rns_2023-11-03_062c87ae-958a-444f-8563-271175e312f0.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3878S

Bellevue Healthcare Trust PLC

03 November 2023

BELLEVUE HEALTHCARE TRUST PLC (the "Company")

LEGAL ENTITY IDENTIFIER ('LEI'): 213800HQ3J3H9YF2UI8

3 November 2023

REDEMPTION OF ORDINARY SHARES

As per its announcement on 20 July 2023, the Company has a redemption facility through which shareholders are entitled to request the redemption of all or part of their holding of ordinary shares on an annual basis.

The total number of ordinary shares in respect of which  redemption requests were received for the 30 November 2023 Redemption Point was 77,428,034 (representing 14.3% of the Company's issued share capital (excluding treasury shares)). The Directors are minded to approve all valid redemption requests. The Company continues to perform the appropriate checks (including section 793 notices, if required) of shareholders where it cannot identify the ultimate beneficial owner.

A further announcement will be made shortly after the 2023 Redemption Point setting out the Redemption Price.

Defined terms in the announcement have the same meaning as set out in the Articles of Association, a copy of which may be obtained from the Company Secretary.

Enquiries:

Apex Listed Companies Services (UK) Limited                     020 3327 9720

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEASFDEFSDFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.